Print

Print


Wonderful to see you posting again, Murray!

Ted and Carole



----- Original Message -----
From: "Murray Charters" <[log in to unmask]>
To: <[log in to unmask]>
Sent: Wednesday, July 21, 2004 2:58 AM
Subject: Mucuna pruriens in Parkinson?s disease


> Article from WE MOVE ()
> July 19, 2004
> H. pylori Eradication, Seed Powder Treatment
> E-MOVE reports from the Eight International Congress of Parkinson's
Disease and
> Movement Disorders, Rome June 14-17, 2004. Page (S) and poster (P) numbers
> are from Movement Disorders 2004;19 (suppleme
>
>
> 1. Long-term effects of Helicobacter pylori eradication on L-Dopa
absorption in
> Parkinson's disease patients
> L Brusa, A Pietroiusti, M Pierantozzi, S Galati, E Fedele, P Stanzione
> P1133, S387
>
> Eradication of Helicobacter pylori improves levodopa pharmacokinetics,
according
> to this study.
>
> Twenty-five patients with H. pylori infection and unsatisfactory levodopa
response
> received placebo followed by either H. pylori eradication therapy or
antioxidant
> therapy with allopurinol. Pharmacokinetic, clinical, and histological
response was
> gauged at 2 weeks and 3 months after treatment. Compared to placebo and
> allopurinol, eradication therapy increased levodopa C-max and area under
the
> curve, with maximal benefits at 3 months, correlated with improvements in
gastritis
> and duodenitis.
>
> The authors suggest that testing for and treatment of infection in PD
patients with
> motor fluctuations may be beneficial.
>
> 2. Mucuna pruriens in Parkinson's disease: A double-blind clinical and
> pharmacological study
> R Katzenschlager, A Evans, A Manson, PN Patsalos, N Ratnaraj, H Watt, L
> Timmermann, R Van de Giessen, AJ Lees
> P710, S249
>
> Levodopa-containing seed powder from Mucuna pruriens (cowhage, velvet
bean,
> atmagupta) produces a rapid-onset symptomatic treatment for Parkinson's
disease,
> according to this study.
>
> Eight patients with dyskinesias were randomized to receive either 200 mg
levodopa
> or 15 or 30 mg M. pruriens followed by crossover. Onset of effect for the
30 mg
> dose was 34.6 minutes, vs. 68.5 minutes for levodopa (p = 0.021). Mean on
time
> was 22% longer and area under the curve was 165% larger. No differences
were
> seen in dyskinesias as assessed by two blinded video raters.
>
> ----------------------------------------------------------------------
> To sign-off Parkinsn send a message to:
mailto:[log in to unmask]
> In the body of the message put: signoff parkinsn
>

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn